Cancer incidence in Beijing, 2014
|
摘要
Objective: To analyze cancer incidence data in Beijing in 2014 and temporal trends for selected common cancers during 2005 and 2014.Methods: A total of 144 secondary and tertiary hospitals reported newly diagnosed cancer cases to Beijing Cancer Registry, which covers 13 million residents in Beijing. The cancer incidence rate was calculated in strata by cancer type, sex, age group and area. The population composition of China in 1982 and Segi's population structure were used to calculate age-standardized rates. Extensive procedures were used to assure the quality of the data.Results: The overall data quality indicators of the percentage of morphology verification(MV)(%), the percentage of death certificate-only(DCO)(%) and the mortality to incidence ratio(M/I) were 72.15%, 0.94% and0.54 respectively. A total of 45,300 new cancer cases were diagnosed in Beijing in 2014. The incidence rate was341.92/100,000(343.50/100,000 in males, 340.33/100,000 in females), and the age-standardized incidence rates by Chinese standard population(ASIRC) and by world standard population(ASIRW) were 143.48/100,000 and182.99/100,000, respectively. The cumulative incidence rate for cancer before 75 years was 20.61%. Cancers of lung, colorectum, liver, stomach and prostate were the top five common cancer types for males, while cancers of breast, lung, thyroid, colorectum and uterus were the top five common cancer types for females. The different patterns were also observed between rural and urban areas. Regarding temporal trends, the incidence of thyroid cancer has the fastest growth between 2005 and 2014. The incidence of liver cancer decreased, and stomach and esophageal cancer also decreased significantly for males in the last decade. Incidence rate for lung cancer was relatively stable during that period of time.Conclusions: With more than 45,000 new cases in Beijing in 2014, cancer remains an important public health problem. Actions should be taken to diminish total cancer incidence in Beijing.
Objective: To analyze cancer incidence data in Beijing in 2014 and temporal trends for selected common cancers during 2005 and 2014.Methods: A total of 144 secondary and tertiary hospitals reported newly diagnosed cancer cases to Beijing Cancer Registry, which covers 13 million residents in Beijing. The cancer incidence rate was calculated in strata by cancer type, sex, age group and area. The population composition of China in 1982 and Segi's population structure were used to calculate age-standardized rates. Extensive procedures were used to assure the quality of the data.Results: The overall data quality indicators of the percentage of morphology verification(MV)(%), the percentage of death certificate-only(DCO)(%) and the mortality to incidence ratio(M/I) were 72.15%, 0.94% and0.54 respectively. A total of 45,300 new cancer cases were diagnosed in Beijing in 2014. The incidence rate was341.92/100,000(343.50/100,000 in males, 340.33/100,000 in females), and the age-standardized incidence rates by Chinese standard population(ASIRC) and by world standard population(ASIRW) were 143.48/100,000 and182.99/100,000, respectively. The cumulative incidence rate for cancer before 75 years was 20.61%. Cancers of lung, colorectum, liver, stomach and prostate were the top five common cancer types for males, while cancers of breast, lung, thyroid, colorectum and uterus were the top five common cancer types for females. The different patterns were also observed between rural and urban areas. Regarding temporal trends, the incidence of thyroid cancer has the fastest growth between 2005 and 2014. The incidence of liver cancer decreased, and stomach and esophageal cancer also decreased significantly for males in the last decade. Incidence rate for lung cancer was relatively stable during that period of time.Conclusions: With more than 45,000 new cases in Beijing in 2014, cancer remains an important public health problem. Actions should be taken to diminish total cancer incidence in Beijing.
Objective: To analyze cancer incidence data in Beijing in 2014 and temporal trends for selected common cancers during 2005 and 2014.Methods: A total of 144 secondary and tertiary hospitals reported newly diagnosed cancer cases to Beijing Cancer Registry, which covers 13 million residents in Beijing. The cancer incidence rate was calculated in strata by cancer type, sex, age group and area. The population composition of China in 1982 and Segi's population structure were used to calculate age-standardized rates. Extensive procedures were used to assure the quality of the data.Results: The overall data quality indicators of the percentage of morphology verification(MV)(%), the percentage of death certificate-only(DCO)(%) and the mortality to incidence ratio(M/I) were 72.15%, 0.94% and0.54 respectively. A total of 45,300 new cancer cases were diagnosed in Beijing in 2014. The incidence rate was341.92/100,000(343.50/100,000 in males, 340.33/100,000 in females), and the age-standardized incidence rates by Chinese standard population(ASIRC) and by world standard population(ASIRW) were 143.48/100,000 and182.99/100,000, respectively. The cumulative incidence rate for cancer before 75 years was 20.61%. Cancers of lung, colorectum, liver, stomach and prostate were the top five common cancer types for males, while cancers of breast, lung, thyroid, colorectum and uterus were the top five common cancer types for females. The different patterns were also observed between rural and urban areas. Regarding temporal trends, the incidence of thyroid cancer has the fastest growth between 2005 and 2014. The incidence of liver cancer decreased, and stomach and esophageal cancer also decreased significantly for males in the last decade. Incidence rate for lung cancer was relatively stable during that period of time.Conclusions: With more than 45,000 new cases in Beijing in 2014, cancer remains an important public health problem. Actions should be taken to diminish total cancer incidence in Beijing.
引文
1.National Bureau of Statistics of China.China Statistical Yearbook,2010.Beijing:China Statistics Press,2010.
2.Ferlay J,Soerjomataram I,Ervik M,et al.GLOBOCAN 2012,Cancer Incidence and Mortality Worldwide:IARC Cancer Base No.11;Lyon;IARC.2013.Available online:http://globocan.iarc.fr
3.People’s Government of Beijing Municipality.Beijing Hygiene and Population Health Report,2014.Beijing:People’s Medical Publishing House,2015.
4.IARC,WHO,IACR,ENCR.International rules for multiple primary cancers(ICD-O Third Edition).Lyon,France:International Agency for Research on Cancer,2004.Available online:http://www.iacr.com.fr/images/doc/MPrules_july2004.pdf
5.Curado MP,Edwards B,Shin HR,et al.Cancer Incidence in Five Continents.Vol.IX.Lyon:IARC,2008:1-837.
6.National Cancer Center.Chinese guideline for cancer registration.Beijing:People’s Medical Publishing House,2016.
7.Ahmad OB,Boschi-pinto C,Lopez AD,et al.Age standardization of rates:a new WHO standard.GPEDiscuss Pap Ser 2001;(31):1-14.Available online:http://www.who.int/healthinfo/paper31.pdf
8.Joinpoint Regression Program,Version 3.4.3,2017.Statistical Methodology and Applications Branch,Surveillance Research Program,National Cancer Institute.
9.Ferlay J.The IARCcrg Tools Programs.Lyon:IARC,2006.Available online:http://www.iacr.com.fr/index.php?option=com_content&viewcategory&layoutblog&id68&Itemid445
10.Fei FR,Hu RY,Zhong JM,et al.Morbidity and mortality of malignant tumor in Zhejiang province,2014.Zhonghua Liu Xing Bing Xue Za Zhi(in Chinese)2016;37:694-8.
11.Chen W,Zheng R,Zhang S,et al.Cancer incidence and mortality in China in 2013:an analysis based on urbanization level.Chin J Cancer Res 2017;29:1-10.
12.Chen W,Zheng R,Zhang S,et al.Cancer incidence and mortality in China,2013.Cancer Lett 2017;401:63-71.
13.Wu J,Zhang W,Han L,et al.A sero-epidemiological study on hepatitis B among general population in Beijing.Zhonghua Liu Xing Bing Xue Za Zhi(inChinese)2007;28:555-7.
14.Gao P,Wang H,Chen WX,et al.A seroepidemiological study of hepatitis B among general population in Beijing.Zhonghua Liu Xing Bing Xue Za Zhi(in Chinese)2016;37:658-62.
15.Cogliano VJ,Baan R,Straif K,et al.Preventable exposures associated with human cancers.J Natl Cancer Inst 2010;103:1827-39.
16.Li C,Cui X,Rao Y,et al.Study on the rates of smoking among the residents of Beijing,from 1997 to2004.Zhonghua Liu Xing Bing Xue Za Zhi(in Chinese)2007;28:453-6.
17.Jamal A,King BA,Neff LJ,et al.Current cigarette smoking among adults-United States,2005-2015.MMWR Morb Mortal Wkly Rep 2016;65:1205-11.
18.Mu H,Li Y,Zhang R,et al.Trend of incidence and mortality of thyroid cancer in five cities in Liaoning Province,2000-2011.Zhongguo Zhong Liu(in Chinese)2015;24:889-95.
19.Xiang F,Huang F,Zhang YY,et al.Trend in incidence of thyroid cancer in Jiading district of Shanghai,2003-2013.Zhonghua Yu Fang Yi Xue Za Zhi(in Chinese)2016;50:656-8.
20.Li K,Lin G,Zhou Q,et al.Time trends of the incidence of thyroid cancer in urban Guangzhou,2000-2011.Zhonghua Yu Fang Yi Xue Za Zhi(in Chinese)2015;49:142-6.
21.Liang D,Li D,Shi J,et al.Epidemic trends of thyroid cancer in Hebei Province,2010-2013.Zhongguo Zhong Liu(in Chinese)2016;25:973-8.
22.Sun J,Xu X,Cai Q,et al.Epidemiological study on thyroid cancer in China.Zhongguo Zhong Liu(in Chinese)2013;22:690-3.
23.Yang L,Wang N.Progress of Epidemiology in thyroid Cancer.Zhonghua Yu Fang Yi Xue Za Zhi(in Chinese)2014;48:744-8.
24.Liu S,Zhang X.Epidemiology and management guidelines of thyroid cancer.Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi(in Chinese)2016;51:146-9.
2.Ferlay J,Soerjomataram I,Ervik M,et al.GLOBOCAN 2012,Cancer Incidence and Mortality Worldwide:IARC Cancer Base No.11;Lyon;IARC.2013.Available online:http://globocan.iarc.fr
3.People’s Government of Beijing Municipality.Beijing Hygiene and Population Health Report,2014.Beijing:People’s Medical Publishing House,2015.
4.IARC,WHO,IACR,ENCR.International rules for multiple primary cancers(ICD-O Third Edition).Lyon,France:International Agency for Research on Cancer,2004.Available online:http://www.iacr.com.fr/images/doc/MPrules_july2004.pdf
5.Curado MP,Edwards B,Shin HR,et al.Cancer Incidence in Five Continents.Vol.IX.Lyon:IARC,2008:1-837.
6.National Cancer Center.Chinese guideline for cancer registration.Beijing:People’s Medical Publishing House,2016.
7.Ahmad OB,Boschi-pinto C,Lopez AD,et al.Age standardization of rates:a new WHO standard.GPEDiscuss Pap Ser 2001;(31):1-14.Available online:http://www.who.int/healthinfo/paper31.pdf
8.Joinpoint Regression Program,Version 3.4.3,2017.Statistical Methodology and Applications Branch,Surveillance Research Program,National Cancer Institute.
9.Ferlay J.The IARCcrg Tools Programs.Lyon:IARC,2006.Available online:http://www.iacr.com.fr/index.php?option=com_content&viewcategory&layoutblog&id68&Itemid445
10.Fei FR,Hu RY,Zhong JM,et al.Morbidity and mortality of malignant tumor in Zhejiang province,2014.Zhonghua Liu Xing Bing Xue Za Zhi(in Chinese)2016;37:694-8.
11.Chen W,Zheng R,Zhang S,et al.Cancer incidence and mortality in China in 2013:an analysis based on urbanization level.Chin J Cancer Res 2017;29:1-10.
12.Chen W,Zheng R,Zhang S,et al.Cancer incidence and mortality in China,2013.Cancer Lett 2017;401:63-71.
13.Wu J,Zhang W,Han L,et al.A sero-epidemiological study on hepatitis B among general population in Beijing.Zhonghua Liu Xing Bing Xue Za Zhi(inChinese)2007;28:555-7.
14.Gao P,Wang H,Chen WX,et al.A seroepidemiological study of hepatitis B among general population in Beijing.Zhonghua Liu Xing Bing Xue Za Zhi(in Chinese)2016;37:658-62.
15.Cogliano VJ,Baan R,Straif K,et al.Preventable exposures associated with human cancers.J Natl Cancer Inst 2010;103:1827-39.
16.Li C,Cui X,Rao Y,et al.Study on the rates of smoking among the residents of Beijing,from 1997 to2004.Zhonghua Liu Xing Bing Xue Za Zhi(in Chinese)2007;28:453-6.
17.Jamal A,King BA,Neff LJ,et al.Current cigarette smoking among adults-United States,2005-2015.MMWR Morb Mortal Wkly Rep 2016;65:1205-11.
18.Mu H,Li Y,Zhang R,et al.Trend of incidence and mortality of thyroid cancer in five cities in Liaoning Province,2000-2011.Zhongguo Zhong Liu(in Chinese)2015;24:889-95.
19.Xiang F,Huang F,Zhang YY,et al.Trend in incidence of thyroid cancer in Jiading district of Shanghai,2003-2013.Zhonghua Yu Fang Yi Xue Za Zhi(in Chinese)2016;50:656-8.
20.Li K,Lin G,Zhou Q,et al.Time trends of the incidence of thyroid cancer in urban Guangzhou,2000-2011.Zhonghua Yu Fang Yi Xue Za Zhi(in Chinese)2015;49:142-6.
21.Liang D,Li D,Shi J,et al.Epidemic trends of thyroid cancer in Hebei Province,2010-2013.Zhongguo Zhong Liu(in Chinese)2016;25:973-8.
22.Sun J,Xu X,Cai Q,et al.Epidemiological study on thyroid cancer in China.Zhongguo Zhong Liu(in Chinese)2013;22:690-3.
23.Yang L,Wang N.Progress of Epidemiology in thyroid Cancer.Zhonghua Yu Fang Yi Xue Za Zhi(in Chinese)2014;48:744-8.
24.Liu S,Zhang X.Epidemiology and management guidelines of thyroid cancer.Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi(in Chinese)2016;51:146-9.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |